Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PMS2P12 is classified as a pseudogene related to the PMS2 gene, a key DNA mismatch repair gene. Pseudogenes are genomic DNA sequences similar to normal genes but are generally non-functional and do not encode functional proteins. Multiple PMS2-related pseudogenes exist on chromosome 7, and PMS2P12 is among them. These pseudogenes can complicate the accurate interpretation of genetic analyses due to high sequence similarity with the functional PMS2 gene[2]. Unlike the functional PMS2 gene, which plays critical roles in DNA repair and cancer predisposition, PMS2P12 does not appear to encode a functional protein and has no verified roles in DNA repair or disease. Therefore, PMS2P12 is not considered a receptor, enzyme, or traditional therapeutic/druggable target. Presence of such pseudogenes is notable primarily as a source of potential technical artifacts or misinterpretation in genetic testing[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on PMS1 homolog 2, mismatch repair system component pseudogene 12 (PMS2P12).